Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The material change disclosed is the acquisition of Ordinary Shares by a connected person:
- Connected Person: Mr P C Thomson and Mrs K Thomson.
- Transaction Date: July 9, 2014.
- Price: 1,554.945 pence per Ordinary Share.
- Details: Acquisition of 2 Ordinary Shares under the personal contribution element and 2 Ordinary Shares under the matching element (Company contribution) of the ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Verify the total number of shares held by Mr P C Thomson and Mrs K Thomson post-transaction.
- Confirm the terms of the ShareReward Plan regarding personal contributions and company matching.
- Check the market price of GSK Ordinary Shares on July 9, 2014, to contextualize the transaction price of 1,554.945 pence.